北陸藥業(300016.SZ):陳園園已通過大宗交易減持1.59%的股份
格隆匯 7 月 2日丨北陸藥業(300016.SZ)公佈,公司於2020年7月2日收到公司股東陳園園的通知,陳園園於2020年6月23日至7月1日期間通過大宗交易方式累計減持公司股份784.8837萬股,佔公司總股本比例為1.59%。
陳園園系公司控股股東、實際控制人王代雪的兒媳,董事長、總經理WANG XU的配偶;其所持股份為2017年10月通過司法網絡拍賣平台競拍取得的李曉祥參與公司非公開發行取得的首發後限售股。
根據《深圳證券交易所上市公司股東及董事、監事、高級管理人員減持股份實施細則》規定,陳園園系公司特定股東,因此此次通過大宗交易受讓陳園園減持784.8837萬股公司股份的受讓方在受讓後六個月內不得轉讓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.